News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–36
Matches
40
Sources here
16
Companies here
3
Search results Stored financial headlines

Active search

40 matching headlines

Ticker or company: PMVMain company stories
Clear
Latest

MarketBeat Earnings

PMV Pharmaceuticals (NASDAQ:PMVP) Posts Earnings Results, Beats Expectations By $0.05 EPS

PMV Pharmaceuticals (NASDAQ:PMVP) reported a quarterly loss of $0.34 per share, beating analyst expectations by $0.05. Following the announcement, the stock rose 3.7% to $1.26. Analysts maintain a "Moderate Buy" rating with a $4.00 consensus price target, despite Oppenheimer lowering its target to $5.00.

PMV Pharmaceuticals Releases Q2 2026 Financial Results

PMV Pharmaceuticals reported a narrower loss for Q2 2026, with a loss of $0.34 per share compared to $0.41 in the prior year, marking a 17.1% improvement. The precision oncology company recorded a net loss of $18.1 million as it continues to invest in …

PMVP main company
Sharemaestro market context Price below Trend Line 52 weeks -14.9% PMVP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ovarian cancer drug trial completes enrollment; PMV plans 2027 filing

PMV Pharmaceuticals reported Q2 2026 financial results and clinical progress for rezatapopt, including the completion of enrollment for the primary analysis in its Phase 2 PYNNACLE trial for platinum-resistant/refractory ovarian cancer. The company plans to submit a New Drug Application (NDA) for accelerated approval …

PMVP main company
Sharemaestro market context Price below Trend Line 52 weeks -14.9% PMVP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

PMVP: Net loss narrowed, but liquidity concerns persist as rezatapopt advances toward NDA submission

PMV Pharmaceuticals (PMVP) reported a narrowed net loss of $18.1 million for Q2 2026, with $79.4 million in cash and equivalents. Despite progress with rezatapopt towards an NDA submission in early 2027, the company faces substantial doubt about its ability to continue operations without …

PMVP main company
Sharemaestro market context Price below Trend Line 52 weeks -14.9% PMVP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PMV Pharmaceuticals (PMVP) flags going-concern risk as rezatapopt advances toward NDA

PMV Pharmaceuticals reported a Q2 2026 net loss of $18.1 million and a first-half loss of $36.1 million, disclosing substantial doubt about its ability to continue as a going concern, as current cash resources are only expected to fund operations through Q2 2027. Despite …

PMVP main company
Sharemaestro market context Price below Trend Line 52 weeks -14.9% PMVP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form 8K Pmv Pharmaceuticals Inc For: 14 August By Investing.com

This article from Investing.com announces the filing of a Form 8K by PMV Pharmaceuticals Inc. on August 14th. The brief piece includes the company's stock symbol PMVP and its real-time performance. The core content is minimal, serving primarily as a notification of the regulatory …

PMVP main company
Sharemaestro market context Price below Trend Line 52 weeks -14.9% PMVP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PMV Pharmaceuticals Inc (PMVP) Stock News Today

The article provides a snapshot of PMV Pharmaceuticals Inc (PMVP) stock information, including its current price, market capitalization, and a general overview. It indicates that more news regarding PMVP stock, earnings, analyst ratings, and key developments will be available soon.

PMVP main company
Sharemaestro market context Price below Trend Line 52 weeks -14.9% PMVP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PMVP Q2'26 Earnings: EPS estimate is (0.39) USD

PMV Pharmaceuticals, Inc. (PMVP) is expected to announce its Q2'26 financial results on August 6th, with the earnings call anticipated at 8:00 AM ET. Analysts project a revenue of $0 and an EPS of ($0.39) for the quarter. The article provides a table comparing …

PMVP main company
Sharemaestro market context Price below Trend Line 52 weeks -14.9% PMVP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Eversept Partners LP Invests $2.91 Million in PMV Pharmaceuticals, Inc. $PMVP

Eversept Partners LP has invested $2.91 million in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) by acquiring 2.35 million shares, representing a 4.40% stake in the company. Other institutional investors have also adjusted their holdings. PMV Pharmaceuticals recently reported a quarterly loss of $0.34 per share, beating …

PMVP main company
Sharemaestro market context Price below Trend Line 52 weeks -14.9% PMVP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sio Capital discloses 4.94% PMV Pharmaceuticals (PMVP) stake below 5% threshold

Sio Capital Management, LLC has reported a beneficial ownership of 2,634,137 shares, or 4.94%, of PMV Pharmaceuticals (PMVP) common stock as of June 30, 2026. This stake is held by various client funds for which Sio acts as an investment adviser, with shared voting …

PMVP main company
Sharemaestro market context Price below Trend Line 52 weeks -14.9% PMVP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PMV Pharmaceuticals Inc (PMVP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey attempts to provide a revenue breakdown for PMV Pharmaceuticals Inc (PMVP), including business segments, regional revenue, and profit contributions. However, the core information indicates that these relevant data have not been disclosed by the company. The article therefore primarily highlights …

PMVP main company
Sharemaestro market context Price below Trend Line 52 weeks -14.9% PMVP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PMV Pharmaceuticals Inc (PMVP) Cash Flow

This article provides an in-depth look at the cash flow statement of PMV Pharmaceuticals Inc (PMVP), including operating, investing, and financing cash flows across various fiscal quarters and years. It details quarterly and annual cash flow figures, along with year-over-year percentage changes, and explains …

PMVP main company
Sharemaestro market context Price below Trend Line 52 weeks -14.9% PMVP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PMV Pharmaceuticals Inc (PMVP) Institutional Confidence

This article provides details on the institutional confidence in PMV Pharmaceuticals Inc (PMVP) by listing major institutional shareholders and their shareholdings. Key institutions include BML Capital Management LLC and Tang Capital Management, LLC, with some showing changes in their positions. The article also provides …

PMVP main company
Sharemaestro market context Price below Trend Line 52 weeks -14.9% PMVP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PMVP|PMV Pharmaceuticals Inc|Price:1.240|Chg%:-0.090

This article provides a detailed financial overview of PMV Pharmaceuticals Inc (PMVP), including its stock price, market capitalization, and various financial statements. It highlights key financial indicators such as EPS, net profit, current assets, total assets, total liabilities, and total equity across multiple quarters …

PMVP main company
Sharemaestro market context Price below Trend Line 52 weeks -14.9% PMVP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PMV Pharmaceuticals Inc (PMVP) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of PMV Pharmaceuticals Inc (PMVP), focusing on support, resistance, indicators, and moving averages. It includes a summary of various technical indicators like MACD, RSI, and STOCH, along with data on moving averages to offer a general trading signal. …

PMVP main company
Sharemaestro market context Price below Trend Line 52 weeks -14.9% PMVP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PMV Pharmaceuticals Inc (PMVP) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of PMV Pharmaceuticals Inc (PMVP) dividend and stock split history. It notes that the company has distributed $0.00 in dividends over the past five years. The current stock price, market cap, and recent performance are also presented.

PMVP main company
Sharemaestro market context Price below Trend Line 52 weeks -14.9% PMVP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context